Physician profile
Michael B Lee
NPI 1568474062
$1,240.90
in general payments reported to CMS, 2019-2025
11 companies · $340 in 2025
The $340 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $83.46 · 2020: $15.87 · 2021: $47.25 · 2022: $157 · 2023: $153 · 2024: $444 · 2025: $340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $937.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $937.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $492.20 | 2019-2025 | Euflexxa |
| Miach Orthopaedics, INC. | $402.89 | 2024-2025 | |
| Stryker Corporation | $118.10 | 2024-2025 | Pangea, Variax, Gamma |
| Pacira Pharmaceuticals Incorporated | $43.11 | 2022 | |
| Djo, LLC | $33.52 | 2025 | Donjoy |
| Orthofix Medical, INC. | $32.66 | 2022 | |
| Pfizer INC. | $30.93 | 2024 | |
| Abbott Laboratories | $30.12 | 2021-2022 | |
| Bioventus LLC | $26.91 | 2019 | |
| Avanos Medical | $15.46 | 2023 | On-Q* Pump and Accessories |
| Depuy Synthes Sales INC. | $15.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.